Ibogaine

Technology

Last mentioned: 2d ago

Timeline

  1. Valuation & Closing

    Fair market value determination and finalization of the equity investment transaction.

  2. Put Option Exercised

    PsyLabs Ltd. formally exercises its rights under the Put Option Agreement with Psyence BioMed.

  3. Strategic Investment Announced

    Psyence BioMed announces it will make an equity investment in PsyLabs at fair market value.

Stories mentioning Ibogaine 1

Funding Rounds Neutral

Psyence BioMed to Invest in PsyLabs Following Put Option Exercise

Psyence Biomedical Ltd. (Nasdaq: PBM) has announced a strategic equity investment in PsyLabs Ltd. after the manufacturer exercised its rights under a previously established put option agreement. This move strengthens the relationship between the biopharmaceutical developer and its primary supplier of nature-derived psychedelic compounds.

2 sources